Delivery Order SPE2DB24D1006-SPE2DB24FCEJY
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,761.55 firm fixed price delivery order is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml, a medication used for diabetes management. The contract has an ultimate completion date of May 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml. The $5,662.56 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, on May 25, 2023, with a completion date of May 26, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corporation for the supply of 4,565,828,590 units of the pharmaceutical product Bydureon BCISE 2 mg AutoInject 0.85 mL. The contract has a ceiling value of $1,570.20 and is a Firm Fixed Price contract. The award date was September 16, 2024, and the ultimate completion date is September 17, 2024. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml. The award, valued at $1,677.69, is a firm-fixed-price delivery order with a completion date of December 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Bydureon BCISE 2 mg autoinjector 0.85 ml. The $4,710.60 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a logistics combat support agency for the U.S. Department of Defense. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,931.32 Firm Fixed Price Delivery Order is for the supply of Bydureon BCISE 2 mg autoinjector medication. The contract has an ultimate completion date of August 16, 2022. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.20 firm fixed-price delivery order is for the BYDUREON BCISE 2 MG AUTOINJECT 0.85ML product, with a completion date of May 31, 2024. This award is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $21,786.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Bydureon BCISE 2 mg autoinjectors. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication. The award, valued at $4,990.57, is a firm-fixed-price delivery order with an ultimate completion date of August 28, 2024. This contract is not designated as a set-aside. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts to...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Bydureon BCISE 2 MG Autoinjector 0.85ML. The contract, valued at $1,570.20, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of June 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...